Martin Müller
The forgotten cohort-lessons learned from prehospital trauma death: a retrospective cohort study.
Jakob D, Müller M, Jud S, Albrecht R, Hautz W, Pietsch U. The forgotten cohort-lessons learned from prehospital trauma death: a retrospective cohort study. Scand J Trauma Resusc Emerg Med 2023; 31:37.
Aug 7, 2023The forgotten cohort-lessons learned from prehospital trauma death: a retrospective cohort study.
Aug 7, 2023Scand J Trauma Resusc Emerg Med 2023; 31:37
Jakob Dominik A, Müller Martin, Jud Sebastian, Albrecht Roland, Hautz Wolf E, Pietsch Urs
Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery
Broglie Däppen M, Müller M, Spreitzer S, Lang F, Lutchmaya M, Stauffer E, Espeli V, Martucci F, Bongiovanni M, Foerbs D, Arnoux A, Dettmer M, Arnold A, Stöckli S, Sauter R, Pasche P, Reinhard A, de Leval L, Huber G, Pezier T, Soltermann A, Giger R, Jochum W. Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery. Head & neck 2017; 39:2004-2015.
Jul 10, 2017Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery
Jul 10, 2017Head & neck 2017; 39:2004-2015
Broglie Däppen Martina, Müller Martin, Spreitzer Stefan, Lang Florian, Lutchmaya Mathieu, Stauffer Edouard, Espeli Vittoria, Martucci Francesco, Bongiovanni Massimo, Foerbs Diana, Arnoux Andre, Dettmer Matthias, Arnold Andreas, Stöckli Sandro, Sauter Rafael, Pasche Philippe, Reinhard Antoine, de Leval Laurence, Huber Gerhard F, Pezier Thomas F, Soltermann Alex, Giger Roland, Jochum Wolfram
Atorvastatin added to interferon β for relapsing multiple sclerosis: a randomized controlled trial
Kamm C, Naegelin Y, Kappos L, Tettenborn B, Slotboom J, Müller F, Goebels N, Müller M, Donati F, Schött D, Schwegler G, Burren Y, von Bredow F, Findling O, Humpert S, El-Koussy M, Mattle H. Atorvastatin added to interferon β for relapsing multiple sclerosis: a randomized controlled trial. J Neurol 2012; 259:2401-13.
May 9, 2012Atorvastatin added to interferon β for relapsing multiple sclerosis: a randomized controlled trial
May 9, 2012J Neurol 2012; 259:2401-13
Kamm Christian Philipp, Naegelin Yvonne, Kappos Ludwig, Tettenborn Barbara, Slotboom Johannes, Müller Felix, Goebels Norbert, Müller Martin, Donati Filippo, Schött Dagmar, Schwegler Guido, Burren Yuliya, von Bredow Ferdinand, Findling Oliver, Humpert Sebastian, El-Koussy Marwan, Mattle Heinrich Paul
Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia.
Burchert A, Wölfl S, Schmidt M, Brendel C, Denecke B, Cai D, Odyvanova L, Lahaye T, Müller M, Berg T, Gschaidmeier H, Wittig B, Hehlmann R, Hochhaus A, Neubauer A. Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia. Blood 2002; 101:259-64.
Jun 28, 2002Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia.
Jun 28, 2002Blood 2002; 101:259-64
Burchert Andreas, Wölfl Stefan, Schmidt Manuel, Brendel Cornelia, Denecke Barbara, Cai Dali, Odyvanova Larissa, Lahaye Tanja, Müller Martin, Berg Thomas, Gschaidmeier Harald, Wittig Burghardt, Hehlmann Rüdiger, Hochhaus Andreas, Neubauer Andreas